KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Enterprise Value (2016 - 2026)

Medpace Holdings filings provide 12 years of Enterprise Value readings, the most recent being -$652.7 million for Q1 2026.

  • On a quarterly basis, Enterprise Value fell 47.85% to -$652.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$652.7 million, a 47.85% decrease, with the full-year FY2025 number at -$497.0 million, up 25.75% from a year prior.
  • Enterprise Value hit -$652.7 million in Q1 2026 for Medpace Holdings, down from -$497.0 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$28.3 million in Q4 2022 to a low of -$669.4 million in Q4 2024.
  • Median Enterprise Value over the past 5 years was -$245.4 million (2023), compared with a mean of -$281.1 million.
  • Biggest five-year swings in Enterprise Value: soared 93.87% in 2022 and later crashed 1205.37% in 2024.
  • Medpace Holdings' Enterprise Value stood at -$28.3 million in 2022, then plummeted by 768.38% to -$245.4 million in 2023, then plummeted by 172.74% to -$669.4 million in 2024, then grew by 25.75% to -$497.0 million in 2025, then plummeted by 31.31% to -$652.7 million in 2026.
  • The last three reported values for Enterprise Value were -$652.7 million (Q1 2026), -$497.0 million (Q4 2025), and -$285.4 million (Q3 2025) per Business Quant data.